Cardinal Health, Inc. (CAH)

NYSE · Dublin, Ohio, USA · Founded 1971 · CEO Jason Hollar

Valuation summary

$166.66 fair value versus $272.34 in the market, a difference of -38.8%. Rated Sell.

Fair value per share$166.66
Current share price$272.34
Upside / downside-38.8%
Bear caseN/M
Bull case$923.36
Discount rate (WACC)8.9%
Terminal growth2.60%
Market capitalisation$63B
EV / Sales0.3x

About Cardinal Health, Inc.

Founded in 1971 by Robert Walter as a food wholesaler, Cardinal moved into drug distribution in 1979. Jason Hollar has been chief executive since 2022. It is one of the three companies, with McKesson and Cencora, that deliver most prescription medicines to US pharmacies and hospitals; it also makes and distributes medical products such as gloves and gowns. Revenue is enormous but profit margins are around 1%, so small changes matter.

Investment case

  • Specialty medicines, the fastest-growing part of pharmacy, are an expanding share of its business.
  • Three distributors control the market, which keeps competition orderly.
  • Earnings have beaten expectations repeatedly under current management.

Key risks

  • Margins are wafer-thin and depend on generic drug pricing.
  • Losing a large customer contract can remove a big slice of revenue.
  • Drug pricing policy in Washington is a constant uncertainty.

Revenue by segment

Pharmaceutical and Specialty Solutions92%
Medical Products and Distribution5%
Other businesses3%

Five-year forecast

RevenueFree cash flow
Year 1$281.8B$1.1B
Year 2$309.6B$1.4B
Year 3$339.5B$1.8B
Year 4$371.9B$2.3B
Year 5$406.8B$2.9B

What the street says

A turnaround that worked; now valued closer to its two larger peers.

Comparable companies: MCK · COR · MDLN · HUM · CI · BSX · DXCM · ELV

Open the interactive model, price chart and sensitivity grid →